| SOPHIA GENETICS SF -,05 |
| Schweiz |
| Gesundheit |
| CH1125843347 / A3CVT8 |
| 90B (Frankfurt) / SOPH (NASDAQ) |
| FRA:90B, ETR:90B, 90B:GR, NASDAQ:SOPH |
| - |
| https://www.sophiagenetic.. |
|
Sophia Genetics SA is a global leader in data-driven medicine focused on enabling healthcare institutions to leverage artificial intelligence and data analytics to enhance clinical diagnosis. The company's main purpose is to democratize data-driven m..
>Volltext.. |
| 423.75 Mio. EUR |
| 421.19 Mio. EUR |
| 71.31 Mio. EUR |
| -53.74 Mio. EUR |
| -71.1 Mio. EUR |
| -1.04 EUR |
| 54.84 Mio. EUR |
| 57.44 Mio. EUR |
| -39.36 Mio. EUR |
| 1.4 |
| 13.16% |
| -14.53% |
| - |
| - |
| - |
| SOPHIA GENETICS, SOPHIA GENETIC |
| 27.06.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|